je.st
news
Our #1 M&A Opportunity For 2016
2015-12-01 17:03:21| Biotech - Topix.net
Akorn has returned 30% since it was first disclosed on StW, but it remains a promising long opportunity today. In fact, it is my favorite deal target for 2016.
Tags: opportunity
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||